N-[3-(benzylamino)-1,4-dioxo-1,4-dihydronaphthalen-2-yl]-N-[(4-fluorophenyl)methyl]acetamide manufacturers
- RIPGBM
-
- $32.00
-
2026-09-10
- CAS:355406-76-7
- Purity: 99.86%
- Supply Ability: 10g
|
| | N-[3-(benzylamino)-1,4-dioxo-1,4-dihydronaphthalen-2-yl]-N-[(4-fluorophenyl)methyl]acetamide Basic information |
| Product Name: | N-[3-(benzylamino)-1,4-dioxo-1,4-dihydronaphthalen-2-yl]-N-[(4-fluorophenyl)methyl]acetamide | | Synonyms: | N-[3-(benzylamino)-1,4-dioxo-1,4-dihydronaphthalen-2-yl]-N-[(4-fluorophenyl)methyl]acetamide;RIPGBM;Acetamide, N-[1,4-dihydro-1,4-dioxo-3-[(phenylmethyl)amino]-2-naphthalenyl]-N-[(4-fluorophenyl)methyl]-;Apoptosis,inhibit,RIPGBM,Inhibitor;N-(3-(Benzylamino)-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-N-(4-fluorobenzyl)acetamide;RIP BM;RIPGBM, 10 mM in DMSO;N-(3-(benzylamino)-1,4-dioxy-1,4-dihydronaphthalene-2-yl)-N-(4-fluorobenzyl)acetamide | | CAS: | 355406-76-7 | | MF: | C26H21FN2O3 | | MW: | 428.45 | | EINECS: | | | Product Categories: | | | Mol File: | 355406-76-7.mol | ![N-[3-(benzylamino)-1,4-dioxo-1,4-dihydronaphthalen-2-yl]-N-[(4-fluorophenyl)methyl]acetamide Structure](CAS/20180713/GIF/355406-76-7.gif) |
| | N-[3-(benzylamino)-1,4-dioxo-1,4-dihydronaphthalen-2-yl]-N-[(4-fluorophenyl)methyl]acetamide Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO : 33.33 mg/mL (77.79 mM; Need ultrasonic) | | form | A crystalline solid | | color | Pink to red |
| | N-[3-(benzylamino)-1,4-dioxo-1,4-dihydronaphthalen-2-yl]-N-[(4-fluorophenyl)methyl]acetamide Usage And Synthesis |
| Uses | RIPGBM is a selective inducer of apoptosis in glioblastoma multiforme (GBM) cancer stem cells (CSCs) with an EC50 of ≤500 nM[1]. | | Biological Activity | RIPGBM is a selective inducer of apoptosis in glioblastoma multiforme (GBM) cancer stem cells (CSCs) with an EC50 of ≤500 nM[1].
RIPGBM induces caspase 1-dependent apoptosis by binding to receptor-interacting protein kinase 2 (RIPK2) and acting as a molecular switch, which reduces the formation of a prosurvival RIPK2/ TAK1 complex and increases the formation of a proapoptotic RIPK2/caspase 1 complex[1]. | | storage | Store at -20°C | | References | [1]. Lucki NC, et al. A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancer. Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6435-6440. |
| | N-[3-(benzylamino)-1,4-dioxo-1,4-dihydronaphthalen-2-yl]-N-[(4-fluorophenyl)methyl]acetamide Preparation Products And Raw materials |
|